Paragen Bio

About:

Paragen Bio is a provider of a technology intended to treat autoimmune diseases.

Twitter/X: paragenbio

Top Investors: AbbVie, OneVentures, Medical Research Commercialisation Fund (MRCF)

Description:

Paragen Bio is a provider of a technology intended to treat autoimmune diseases. The company's technology helps in treating diseases which causes the immune system to attack healthy tissues and organs, enabling doctors to stop the deterioration and complete destruction of tissue.

Total Funding Amount:

6M AUD

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Brisbane, Queensland, Australia

Founded Date:

2018-01-01

Founders:

Alex Loukas, John Miles, Norelle Daly, Paul Giacomin

Number of Employees:

11-50

Last Funding Date:

2018-08-14

IPO Status:

Private

Industries: